Physician profile
Richard C Mann
NPI 1942286299
$1,780.77
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $645 · 2020: $468 · 2021: $339 · 2022: $316 · 2023: $13.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $687.26 | 2019-2022 | |
| Amgen INC. | $220.40 | 2019-2021 | |
| Pfizer INC. | $183.35 | 2019-2022 | |
| Astellas Pharma US INC | $171.24 | 2019-2022 | |
| Therapeuticsmd, INC. | $116.00 | 2019-2022 | |
| Allergan, INC. | $74.13 | 2019-2020 | |
| Radius Health, INC. | $46.44 | 2022 | |
| Avion Pharmaceuticals | $35.10 | 2020 | |
| Axonics, INC. | $29.24 | 2021-2023 | Axonics |
| Myovant Sciences INC. | $28.73 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $28.40 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.51 | 2019-2020 | |
| Mycovia Pharmaceuticals, INC. | $24.63 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.10 | 2021 | |
| Bausch Health US, LLC | $19.28 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $17.27 | 2020 | |
| Covidien LP | $15.14 | 2020 | |
| Merck Sharp & Dohme LLC | $13.23 | 2019 | |
| Minerva Surgical, INC | $11.99 | 2019 | |
| Lupin INC. | $11.33 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.